碳酸锂治疗甲亢的有效性和安全性

Efficacy and safety of lithium carbonate therapy in patients with hyperthyroidism

碳酸锂是用于治疗急性躁狂症及预防双向精神障碍的基础药物.在治疗过程中,人们发现该药尚能够降低甲状腺激素水平,造成患者甲状腺功能减退.受此启发,碳酸锂被作为甲状腺功能亢进症（甲亢）的二线用药.但是,使用这种药物治疗甲亢的方案并不统一,其有效性和安全性问题亦值得进一步研究和探索.

Lithium carbonate is a fundamental drug used in the management of acute mania and prophylaxis of bipolar disorders.It has been found that some patients on lithium carbonate therapy developed hypothyroidism.Therefore,this medication becomes a second-line choice for the treatment of patients with hyperthyoidism,though no standardized protocol has been approved.It remains worthwhile to investigate the efficacy and safety profiles of lithium carbonate in the management of hyperthyroidism.